Are there Clinically Significant Differences Among Immune Checkpoint Inhibitors Treating Lung Cancer? episode artwork

EPISODE · Nov 4, 2015 · 2 MIN

Are there Clinically Significant Differences Among Immune Checkpoint Inhibitors Treating Lung Cancer?

from GRACEcast · host cancerGRACE Meetings

Drs. Leora Horn, Ben Solomon, & Jack West consider whether the data suggest that the better tested PD1 and PD-L1 inhibitors have differences in activity or tolerability or are essentially interchangeable.

Episode metadata supplied by the publisher feed · Published Nov 4, 2015

Embed this episode

NOW PLAYING

Are there Clinically Significant Differences Among Immune Checkpoint Inhibitors Treating Lung Cancer?

0:00 2:54

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of GRACEcast?

This episode is 2 minutes long.

When was this GRACEcast episode published?

This episode was published on November 4, 2015.

Can I download this GRACEcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!